» Articles » PMID: 26284062

The Extended Family of CD1d-Restricted NKT Cells: Sifting Through a Mixed Bag of TCRs, Antigens, and Functions

Overview
Journal Front Immunol
Date 2015 Aug 19
PMID 26284062
Citations 48
Authors
Affiliations
Soon will be listed here.
Abstract

Natural killer T (NKT) cells comprise a family of specialized T cells that recognize lipid antigens presented by CD1d. Based on their T cell receptor (TCR) usage and antigen specificities, CD1d-restricted NKT cells have been divided into two main subsets: type I NKT cells that use a canonical invariant TCR α-chain and recognize α-galactosylceramide (α-GalCer), and type II NKT cells that use a more diverse αβ TCR repertoire and do not recognize α-GalCer. In addition, α-GalCer-reactive NKT cells that use non-canonical αβ TCRs and CD1d-restricted T cells that use γδ or δ/αβ TCRs have recently been identified, revealing further diversity among CD1d-restricted T cells. Importantly, in addition to their distinct antigen specificities, functional differences are beginning to emerge between the different members of the CD1d-restricted T cell family. In this review, while using type I NKT cells as comparison, we will focus on type II NKT cells and the other non-invariant CD1d-restricted T cell subsets, and discuss our current understanding of the antigens they recognize, the formation of stimulatory CD1d/antigen complexes, the modes of TCR-mediated antigen recognition, and the mechanisms and consequences of their activation that underlie their function in antimicrobial responses, anti-tumor immunity, and autoimmunity.

Citing Articles

Cellular Output and Physicochemical Properties of the Membrane-Derived Vesicles Depend on Chemical Stimulants.

Shrestha D, Bahasoan Y, Eggeling C ACS Appl Mater Interfaces. 2024; 16(37):48982-48992.

PMID: 39250321 PMC: 11420866. DOI: 10.1021/acsami.4c07234.


Cutting Edge: Redundant Roles for MHC Class II-, CD1d-, and MR1-restricted T Cells in Clearing Bartonella Infection.

Siewert L, Fromm K, Dehio C, Pinschewer D J Immunol. 2024; 213(5):553-558.

PMID: 38984869 PMC: 11335324. DOI: 10.4049/jimmunol.2400045.


The role of natural killer T cells in liver transplantation.

Zhao W, Li M, Song S, Zhi Y, Huan C, Lv G Front Cell Dev Biol. 2024; 11:1274361.

PMID: 38250325 PMC: 10796773. DOI: 10.3389/fcell.2023.1274361.


Natural Killer T Cell Diversity and Immunotherapy.

Tognarelli E, Gutierrez-Vera C, Palacios P, Pasten-Ferrada I, Aguirre-Munoz F, Cornejo D Cancers (Basel). 2023; 15(24).

PMID: 38136283 PMC: 10742272. DOI: 10.3390/cancers15245737.


Thymus-derived hormonal and cellular control of cancer.

Savino W, Lepletier A Front Endocrinol (Lausanne). 2023; 14:1168186.

PMID: 37529610 PMC: 10389273. DOI: 10.3389/fendo.2023.1168186.


References
1.
Tyznik A, Tupin E, Nagarajan N, Her M, Benedict C, Kronenberg M . Cutting edge: the mechanism of invariant NKT cell responses to viral danger signals. J Immunol. 2008; 181(7):4452-6. PMC: 2597678. DOI: 10.4049/jimmunol.181.7.4452. View

2.
Vilarinho S, Ogasawara K, Nishimura S, Lanier L, Baron J . Blockade of NKG2D on NKT cells prevents hepatitis and the acute immune response to hepatitis B virus. Proc Natl Acad Sci U S A. 2007; 104(46):18187-92. PMC: 2084318. DOI: 10.1073/pnas.0708968104. View

3.
Rhost S, Lofbom L, Rynmark B, Pei B, Mansson J, Teneberg S . Identification of novel glycolipid ligands activating a sulfatide-reactive, CD1d-restricted, type II natural killer T lymphocyte. Eur J Immunol. 2012; 42(11):2851-60. DOI: 10.1002/eji.201142350. View

4.
Hayday A, Vantourout P . A long-playing CD about the γδ TCR repertoire. Immunity. 2013; 39(6):994-6. DOI: 10.1016/j.immuni.2013.11.016. View

5.
Rolf J, Berntman E, Stenstrom M, Smith E, Mansson R, Stenstad H . Molecular profiling reveals distinct functional attributes of CD1d-restricted natural killer (NK) T cell subsets. Mol Immunol. 2008; 45(9):2607-20. DOI: 10.1016/j.molimm.2007.12.022. View